British scientists will conduct a study to determine the effectiveness of aspirin as a possible treatment for coronavirus, reports show.
The RECOVERY trial will attempt to evaluate a range of treatment options, including low-dose dexamethasone, azithromycin, convalescent plasma, and aspirin, among others, according to the trial’s website.
The focus on aspirin will determine whether aspirin could help reduce the risk of blood clots in people with COVID-19, Reuters reported.
Patients infected with the virus are at greater risk of blood clots due to hyper-reactive platelets, and aspirin is an antiplatelet agent.
ORGANIZER UK RAVE OBTAINS $ 13B FOR BREACH OF CORONAVIRUS RESTRICTIONS
At least 2,000 patients are expected to participate in what would be one of the UK’s largest trials. Each participant would receive 150 mg. daily dose of aspirin. These patients will be compared to 2,000 others who only receive standard treatments.
The study will primarily look at patient mortality after 28 days while assessing length of hospital stay and need for ventilation, Politico reported.
EUROPE CELEBRATES BIDEN WIN WITH FIREWORKS AND CHURCH BELLS
“Aspirin is widely used to prevent blood clots in many other conditions, including heart attacks, strokes and pre-eclampsia in pregnant women,” said Prof Martin Landray, co-investigator in leader of the test.
“But recruiting patients into a randomized trial such as Recovery is the only way to assess whether there are clear benefits for patients with COVID-19 and whether those benefits outweigh potential side effects, such as the risk of bleeding.
Other treatments tested in the recovery trial included antibody-rich plasma taken from recovered COVID-19 patients and the Regeneron antibody cocktail that was used to treat Donald’s COVID-19 symptoms. Trump.
CLICK HERE FOR THE FOX NEWS APP
The results of these trials will likely take months to determine, but if aspirin was found to be effective, it would be a cheap option to help regulate symptoms.